Alexey Navalny Poisoned by a Nerve Agent - German Doctors

Published September 3rd, 2020 - 06:46 GMT
Tests carried out on Russian opposition leader Alexei Navalny provide clear proof that he was poisoned by a chemical nerve agent, the German government said Wednesday, September 2, 2020, demanding explanations from Moscow. Odd ANDERSEN / AFP
Tests carried out on Russian opposition leader Alexei Navalny provide clear proof that he was poisoned by a chemical nerve agent, the German government said Wednesday, September 2, 2020, demanding explanations from Moscow. Odd ANDERSEN / AFP
Highlights
'Unequivocal' evidence found nerve agent used to poison Russian opposition leader Alexey Navalny, say local media reports.

Germany has found “unequivocal” evidence that a nerve agent was used to poison Russian opposition leader Alexey Navalny last month, local media reported Wednesday. 

In tests run by a special German military laboratory, signs of "a chemical nerve agent from the Novichok party" were found, Steffen Seiber, Chancellor Angela Merkel's spokesman, said in a statement.

The nerve agent Novichok was also used in the 2018 poisoning of ex-Soviet spy Sergei Skripal and his daughter in the British town of Salisbury in an attack by Russian intelligence, according to the UK government.


German doctors at a clinic where the opposition leader is being treated announced last week that Navalny had been poisoned.

Navalny is currently in intensive care in a medically induced coma. His condition is serious, but there is no acute danger to his life, say his doctors.

Navalny, 44, a vociferous critic of Russian President Vladimir Putin, fell ill on Aug. 20 on a flight from the Siberian city of Tomsk to Moscow. The plane made an emergency landing in Omsk and Navalny was rushed to a hospital, where he spent two days before being sent to Berlin for treatment.

Commenting on the incident, Kremlin spokesman Dmitry Peskov earlier said they were waiting for test results before launching an investigation.

This article has been adapted from its original source.

Subscribe

Sign up to our newsletter for exclusive updates and enhanced content